Economic Review

The Institute for Clinical and Economic Review (ICER) is an independent, non-profit research organization that evaluates the clinical and economic value of prescription drugs, medical tests, and other healthcare innovations. Founded in 2006, ICER provides objective evidence-based reports that are widely used by U.S. health insurers, pharmaceutical companies, and policymakers to inform pricing and coverage decisions. The organization is best known for its value assessment reports, which utilize metrics like the quality-adjusted life-year (QALY) to determine fair pricing benchmarks for new therapies. ICER's work aims to improve patient access to high-value care while ensuring that healthcare costs remain sustainable for the system.